Cargando…
A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitors
BACKGROUND: Maturation inhibitors (MIs) potently block HIV-1 maturation by inhibiting the cleavage of the capsid protein and spacer peptide 1 (CA-SP1). Bevirimat (BVM), a highly efficacious first-in-class MI against HIV-1 subtype B isolates, elicited sub-optimal efficacy in clinical trials due to po...
Autores principales: | Ghimire, Dibya, KC, Yuvraj, Timilsina, Uddhav, Goel, Kriti, Nitz, T. J., Wild, Carl T., Gaur, Ritu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033686/ https://www.ncbi.nlm.nih.gov/pubmed/33836787 http://dx.doi.org/10.1186/s12977-021-00553-5 |
Ejemplares similares
-
Identification of potent maturation inhibitors against HIV-1 clade C
por: Timilsina, Uddhav, et al.
Publicado: (2016) -
Insights into the activity of maturation inhibitor PF-46396 on HIV-1 clade C
por: Ghimire, Dibya, et al.
Publicado: (2017) -
The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles
por: Nguyen, Albert T, et al.
Publicado: (2011) -
Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1maturation inhibitor bevirimat
por: Adamson, Catherine S, et al.
Publicado: (2010) -
HIV-1 Subtype A Gag Variability and Epitope Evolution
por: Abidi, Syed Hani, et al.
Publicado: (2014)